Clinical Trial

Cognitive Function and Fatigue After Brain Abscess

Recruiting
View on ClinicalTrials.gov →
Summary
Brain abscess is a focal bacterial or fungal infection of the brain. Treatment is neurosurgical drainage of pus followed by long-term antibiotic treatment. In spite of successful treatment of the infection, long-term cognitive problems or mental fatigue may ensue. The reason for this dysfunction may be a continuing inflammatory state or damage to brain tissue caused by the abscess. The investigators will evaluate these possibilities with the use of \[18F\]deoxyglucose-positron emission tomography (FDG-PET) and electroencephalography (EEG) in patients who have been treated for brain abscess and who experience cognitive problems and/or fatigue. FDG-PET may identify both inflammation and altered neuronal activity (the latter indicating damage to brain tissue), and EEG may identify altered neuronal activity, including changes in neuronal network activity.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-06-23; most recent amendment 2025-07-01.
Trial Details
NCT Number NCT04938362
Lead Sponsor University of Oslo
Collaborators: Oslo University Hospital, Sunnaas Rehabilitation Hospital
Conditions Brain Abscess, Fatigue, Cognitive Dysfunction
Enrollment 50 participants
Start Date 2020-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-04